Michael Robert Feilmeier

Michael Feilmeier practices at Midwest Eye Surgery Center in Omaha, Nebraska.

Michael Feilmeier's NPI, 1245440437, was assigned on May 23, 2007. Michael Feilmeier graduated from University of Nebraska College of Medicine in 2005. Michael Feilmeier holds Nebraska license 25597.

Michael Feilmeier's primary practice is Midwest Eye Surgery Center, at 4353 Dodge Street, Omaha, NE 68131. The practice phone is (402) 552-2020.

Michael Feilmeier's primary practice is Midwest Eye Surgery Center in Omaha, Nebraska. Michael Feilmeier is also affiliated with Nebraska Medical Center. Dmand AI also links Michael Feilmeier to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Feilmeier practices, 6 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Michael Feilmeier's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Michael Feilmeier's licenses on file in 2 states: Nebraska and Iowa.

CMS data shows 4,454 Medicare services from Michael Feilmeier across 21 procedure codes in 2024, for 1,632 Medicare patients. Medicare paid $576,597 for them.

CMS counts 1,632 Medicare patients who saw Michael Feilmeier in 2026. The largest group is 75 to 84, with 725 patients. 71% of them have high blood pressure, and 71% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michael Feilmeier's median patient age at 74, with 58% women.

In 2026, Michael Feilmeier wrote 2,932 Medicare Part D claims for 718 patients. 57% of them were for generic drugs. CMS names the drug for 2,848 of them, across 22 drugs with 11 or more claims each, at $133,529 in total drug cost. In 2023, CMS named 2,536 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Michael Feilmeier for performance year 2026, reported as part of a group. Michael Feilmeier accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,285 procedures of cataract surgery by Michael Feilmeier, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Michael Feilmeier. Michael Feilmeier has published most often in Cornea. Michael Feilmeier's most frequent co-authors are Eduardo Alfonso, MD, Geoffrey C. Tabin, MD and Sonia H. Yoo, MD.

Dmand AI links Michael Feilmeier to 1 clinical trial. Conditions studied include Refractive Errors and Eye Diseases.

CMS Open Payments shows 15 general payments to Michael Feilmeier from 3 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 92% of the total. RxSight Inc paid the most, $267.

Michael Feilmeier graduated from University of Nebraska College of Medicine in 2005.